Do you want to visit this external website and leave amgenpro.com.au?
You are now leaving this Amgen Australia website. Amgen Australia assumes no responsibility for, and exercises no control over, the organizations, opinions, or accuracy of the information on the server or website you are redirected to.
Do you want to visit this external website and leave amgenpro.com.au?
You are now leaving this Amgen Australia website. Amgen Australia assumes no responsibility for, and exercises no control over, the organizations, opinions, or accuracy of the information on the server or website you are redirected to.
You can paste this link into an email or message to share this resource with your patient.
Immune thrombocytopenia (ITP) is an acquired autoimmune disorder defined by immune-mediated platelet and impaired thrombopoiesis, resulting in thrombocytopenia (platelet count <100×10⁹/L) and increased bleeding risk. Diagnosis is by exclusion, and ITP is classified as primary or secondary based on the presence of underlying conditions.
AmgenPro is intended for healthcare professionals in Australia
Login or create an AmgenPro account to access the latest updates on our products, medical resources and patient programs.